首页 | 本学科首页   官方微博 | 高级检索  
     

MVP和MOP方案治疗晚期非小细胞肺癌的临床疗效观察
引用本文:赵夕武,李坚,张兰石. MVP和MOP方案治疗晚期非小细胞肺癌的临床疗效观察[J]. 江苏大学学报(医学版), 2001, 11(1): 2-4
作者姓名:赵夕武  李坚  张兰石
作者单位:镇江医学院附属医院呼吸内科,江苏,镇江,212001;镇江医学院附属医院呼吸内科,江苏,镇江,212001;镇江医学院附属医院呼吸内科,江苏,镇江,212001
摘    要:目的比较长春地辛(VDS)、丝裂霉素(MMC)和顺铂(DDP)组成的MVP方案及长春新硷(VCR)、丝裂霉素和顺铂组成的MOP方案治疗晚期非小细胞肺癌的疗效.方法72例晚期非小细胞肺癌(NSCLC)随机分成两组,每例至少化疗两疗程.疗效及毒性反应按WHO标准进行评价.结果MVP组有效率为60.5%,MOP组有效率为23.5%,两组比较有显著差异(P<0.05).对VCR耐药病例应用VDS后仍有良好疗效.MVP组的骨髓抑制和胃肠道反应较MOP组明显(P<0.05).结论MVP方案是治疗晚期非小细胞肺癌有效率较高的方案之一,其毒副反应可为多数病人所耐受.

关 键 词:长春地辛  长春新硷  非小细胞肺癌  联合化疗
文章编号:1006-7655(2001)01-002-03
修稿时间:2000-11-10

A Comparison of the Therapeutic of MVP and MOP Regimen for Treatment of Advanced non-small Cell Lung Cancer
ZHAO Xiwu,LI Jian,ZHANG Lanshi. A Comparison of the Therapeutic of MVP and MOP Regimen for Treatment of Advanced non-small Cell Lung Cancer[J]. Journal of Jiangsu University Medicine Edition, 2001, 11(1): 2-4
Authors:ZHAO Xiwu  LI Jian  ZHANG Lanshi
Abstract:Objective:To evaluate the curative effects of MVP(MMC VDS DDP)regimen on advanced non-small cell lung cancer.Methods:72 cases of advanced nonsmall lung cancer were randomly divided into two groups.Each patient was received at least 2 cycles combinant chemotherapy.The efficacy and the toxicity were assessed according to WHO criteria.Result:The result showed that response rates of MVP regimen and MOP regimen were 60.5% and 23.5% respectively.There was statistical significant difference between them(P<0.05).And VDS also have good effect on patients who were resistant to VCR.Myclosuppression and gastrointestinal tract reaction in MVP group were serious than that in MOP group.Conclusion:MVP is one of high effective regimes used for treatment of advanced NSCLC,whose toxicity can be endured by large part of patients.
Keywords:Vindesine  Nincristine  Non-small cell Lung cancer  Combinant chemotherapy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号